Company Filing History:
Years Active: 2017-2022
Title: Wei-Jong Shia: Innovator in Cancer Treatment
Introduction
Wei-Jong Shia is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative work on arginine deiminase proteins. With a total of 2 patents, his research focuses on enhancing the efficacy of treatments for arginine-dependent diseases.
Latest Patents
Wei-Jong Shia's latest patents include advancements in arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatment. The present invention relates to isolated arginine deiminase (ADI) proteins that exhibit reduced cross-reactivity with anti-ADI-PEG 20 antibodies compared to ADI-PEG 20. These proteins maintain functional characteristics that are comparable to or better than ADI-PEG 20. The compositions comprising these ADI proteins are aimed at treating arginine-dependent diseases, including various forms of cancer.
Career Highlights
Throughout his career, Wei-Jong Shia has worked with prominent companies such as Polaris Group and Tdw Group. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.
Collaborations
Wei-Jong Shia has collaborated with notable professionals in his field, including Richard E Showalter and Robert Almassy. These collaborations have further enriched his research and development efforts.
Conclusion
Wei-Jong Shia stands out as an influential inventor in the realm of cancer treatment, with his innovative patents paving the way for advancements in medical therapies. His work continues to impact the field positively.